Revenue
No reported data
Werewolf Therapeutics, Inc. (HOWL)
Price—Loading quote
Net income
2020
2021
2022
2023
2024
2025
Free cash flow
2020
2021
2022
2023
2024
2025
Total cash / debt
CashTotal debt
2019
2020
2021
2022
2023
2024
2025
Financial statements
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | |
|---|---|---|---|---|---|---|
| Research & development | $44.8M | $56.4M | $41.8M | $53.8M | $35.3M | $16.6M |
| Operating expenses | $60.7M | $75.5M | $60.4M | $72.5M | $50.1M | $22.4M |
| Operating income | −$60.7M | −$73.6M | −$40.5M | −$56.1M | −$50.1M | −$22.4M |
| Net income | −$60.8M | −$70.5M | −$37.4M | −$53.8M | −$50.0M | −$15.0M |
| Basic EPSper diluted share | -$1.32 | -$1.63 | -$1.05 | -$1.86 | -$10.94 | -$28.08 |
| Diluted EPSper diluted share | -$1.33 | -$1.63 | -$1.05 | -$1.86 | -$10.94 | -$28.08 |
Insider buys & sells
| Transaction | Insider | Type | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| Jun 29, 2026Form 4 · 10b5-1 | EVNIN LUKEDirector | SellCommon Stock · indirect | 157.1K | $0.30 | $47.1K | 143.2K |
| Jun 17, 2026Form 4 | RA CAPITAL MANAGEMENT, L.P. +3TenPercentOwner | SellCommon Stock · indirect | 27.7K | $0.35 | $9.7K | 303.7K |
| Jun 17, 2026Form 4 | RA CAPITAL MANAGEMENT, L.P. +3TenPercentOwner | SellCommon Stock · indirect | 389.2K | $0.35 | $136.2K | 4.27M |
| Jun 16, 2026Form 4 | RA CAPITAL MANAGEMENT, L.P. +3TenPercentOwner | SellCommon Stock · indirect | 9.9K | $0.37 | $3.7K | 331.4K |
| Jun 16, 2026Form 4 | RA CAPITAL MANAGEMENT, L.P. +3TenPercentOwner | SellCommon Stock · indirect | 139.7K | $0.37 | $51.7K | 4.66M |